PIK3CD

Chr 1Digenic recessiveADAR

phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta

Also known as: APDS, IMD14, IMD14A, IMD14B, P110DELTA, PI3K, PI3Kdelta, ROCHIS

Phosphoinositide 3-kinases (PI3Ks) phosphorylate inositol lipids and are involved in the immune response. The protein encoded by this gene is a class I PI3K found primarily in leukocytes. Like other class I PI3Ks (p110-alpha p110-beta, and p110-gamma), the encoded protein binds p85 adapter proteins and GTP-bound RAS. However, unlike the other class I PI3Ks, this protein phosphorylates itself, not p85 protein.[provided by RefSeq, Jul 2010]

GeneReviewsOMIMResearchGenerating clinical summary…
MultiplemechanismDigenic recessive/AD/ARLOEUF 0.203 OMIM phenotypes
Clinical SummaryPIK3CD
🧬
Gene-Disease Validity (ClinGen)
immunodeficiency 14b, autosomal recessive · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

2 total gene-disease associations curated

Population Constraint (gnomAD)
Highly constrained gene — heterozygous loss-of-function variants are very rare in the population (pLI 1.00). One damaged copy is likely sufficient to cause disease.
📋
ClinVar Variants
34 unique Pathogenic / Likely Pathogenic· 415 VUS of 1049 total submissions
📖
GeneReview available — PIK3CD
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Dual constrained — LoF & missense intolerant
LoF Constraint?
0.20LOEUF
pLI 1.000
Z-score 6.15
OE 0.09 (0.050.20)
Highly constrained

Highly LoF-intolerant (top ~10% of genes)

Missense Constraint?
4.27Z-score
OE missense 0.52 (0.480.57)
331 obs / 633.9 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios?
LoF OE?0.09 (0.050.20)
00.351.4
Missense OE?0.52 (0.480.57)
00.61.4
Synonymous OE?1.09
01.21.6
LoF obs/exp: 5 / 53.6Missense obs/exp: 331 / 633.9Syn Z: -1.16

This gene — mechanism propensity

DN
0.3693th %ile
GOF
0.4678th %ile
LOF
0.62top 25%

This gene has evidence for multiple mechanisms of pathogenicity (loss-of-function and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to loss-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

LOF59% of P/LP variants are LoF · LOEUF 0.20
GOF1 literature citation

Literature Evidence

GOFHere we report a dominant gain of function PIK3CD mutation (E1021K) in a patient presenting with recurrent otitis media, massive splenomegaly, and persistent EBV-viraemia.1

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312. Mechanism ranking also informed by gnomAD constraint, ClinVar, and ClinGen data.

References

  1. 1.PMID 28842185

ClinVar Variant Classifications

1049 submitted variants in ClinVar

Classification Summary

Pathogenic20
Likely Pathogenic14
VUS415
Likely Benign516
Benign57
Conflicting7
20
Pathogenic
14
Likely Pathogenic
415
VUS
516
Likely Benign
57
Benign
7
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
17
3
0
0
20
Likely Pathogenic
3
11
0
0
14
VUS
4
360
45
6
415
Likely Benign
0
21
190
305
516
Benign
0
3
38
16
57
Conflicting
7
Total243982733271,029

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

36 pathogenic / likely-pathogenic (of 49) ClinVar copy-number / structural variants overlap PIK3CD — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

PIK3CD · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →